Using chatbots to promote HPV vaccination among ethnic Koreans in the U.S.
Let’s K-Talk: A Storytelling Intervention Leveraging Chatbot Technology to Prevent HPV and HPV Associated Cancers for Ethnic Koreans Living in the U.S.
['FUNDING_OTHER'] · UNIVERSITY OF CINCINNATI · NIH-10895473
This study is testing a friendly chatbot that shares stories and helpful information to encourage ethnic Koreans in the U.S. to get the HPV vaccine, aiming to improve health and reduce cancer risks in the community.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CINCINNATI (nih funded) |
| Locations | 1 site (CINCINNATI, UNITED STATES) |
| Trial ID | NIH-10895473 on ClinicalTrials.gov |
What this research studies
This research aims to develop a storytelling intervention that utilizes chatbot technology to encourage HPV vaccination among ethnic Koreans living in the U.S. The approach focuses on addressing health disparities by creating culturally relevant narratives that resonate with the target population. By leveraging artificial intelligence, the chatbot will provide timely information and motivation for vaccination, ultimately aiming to reduce the incidence of HPV-related infections and cancers. The project is led by Dr. Minjin Kim, a nurse scientist dedicated to improving health outcomes for underserved communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are ethnic Koreans aged 18 to 26 who are at risk for HPV infection and are currently under-vaccinated.
Not a fit: Patients who are already vaccinated against HPV or those outside the targeted age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among ethnic Koreans, leading to a reduction in HPV-related cancers.
How similar studies have performed: Previous research has shown success in using technology and storytelling to improve health behaviors, suggesting that this approach may be effective.
Where this research is happening
CINCINNATI, UNITED STATES
- UNIVERSITY OF CINCINNATI — CINCINNATI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, MINJIN — UNIVERSITY OF CINCINNATI
- Study coordinator: KIM, MINJIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anal Cancer, Anal Cancers, Anus Cancer